161 related articles for article (PubMed ID: 32022596)
1. Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP.
Chen Y; Schaefer JJ; Iyer SR; Harders GE; Pan S; Sangaralingham SJ; Chen HH; Redfield MM; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2020 Apr; 318(4):R669-R676. PubMed ID: 32022596
[TBL] [Abstract][Full Text] [Related]
2. A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.
McKie PM; Cataliotti A; Huntley BK; Martin FL; Olson TM; Burnett JC
J Am Coll Cardiol; 2009 Sep; 54(11):1024-32. PubMed ID: 19729120
[TBL] [Abstract][Full Text] [Related]
3. MANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and Furosemide-Induced Increase in Aldosterone in Hypertension.
Dzhoyashvili NA; Iyer SR; Chen HH; Burnett JC
Hypertension; 2022 Apr; 79(4):750-760. PubMed ID: 35045724
[TBL] [Abstract][Full Text] [Related]
4. MANP Activation Of The cGMP Inhibits Aldosterone Via PDE2 And CYP11B2 In H295R Cells And In Mice.
Chen Y; Iyer SR; Nikolaev VO; Naro F; Pellegrini M; Cardarelli S; Ma X; Lee HC; Burnett JC
Hypertension; 2022 Aug; 79(8):1702-1712. PubMed ID: 35674049
[TBL] [Abstract][Full Text] [Related]
5. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
McKie PM; Cataliotti A; Boerrigter G; Chen HH; Sangaralingham SJ; Martin FL; Ichiki T; Burnett JC
Hypertension; 2010 Dec; 56(6):1152-9. PubMed ID: 20975033
[TBL] [Abstract][Full Text] [Related]
6. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
8. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension.
Cannone V; Burnett JC
Front Physiol; 2021; 12():815796. PubMed ID: 35222065
[TBL] [Abstract][Full Text] [Related]
11. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
12. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
13. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
14. Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate.
Pan S; Chen HH; Correia C; Dai H; Witt TA; Kleppe LS; Burnett JC; Simari RD
PLoS One; 2014; 9(11):e112986. PubMed ID: 25419565
[TBL] [Abstract][Full Text] [Related]
15. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
Goltsman I; Khoury EE; Aronson D; Nativ O; Feuerstein GZ; Winaver J; Abassi Z
J Cell Mol Med; 2019 Jul; 23(7):4779-4794. PubMed ID: 31087547
[TBL] [Abstract][Full Text] [Related]
17. Heart-Microcirculation Connection: Effects of ANP (Atrial Natriuretic Peptide) on Pericytes Participate in the Acute and Chronic Regulation of Arterial Blood Pressure.
Špiranec Spes K; Chen W; Krebes L; Völker K; Abeßer M; Eder Negrin P; Cellini A; Nickel A; Nikolaev VO; Hofmann F; Schuh K; Schweda F; Kuhn M
Hypertension; 2020 Nov; 76(5):1637-1648. PubMed ID: 32951468
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway.
Yamamoto T; Wada A; Tsutamoto T; Ohnishi M; Horie M
J Cardiovasc Pharmacol; 2004 Nov; 44(5):596-600. PubMed ID: 15505498
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal effect of CNAAC: An innovatively designed natriuretic peptide.
Zhang S; Geng X; Zhao L; Li J; Tian F; Wang Y; Fan R; Feng N; Liu J; Cheng L; Pei J
Eur J Pharmacol; 2015 Aug; 761():180-8. PubMed ID: 25979857
[TBL] [Abstract][Full Text] [Related]
20. MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.
Ma X; McKie PM; Iyer SR; Scott C; Bailey K; Johnson BK; Benike SL; Chen H; Miller WL; Cabassi A; Burnett JC; Cannone V
JACC Basic Transl Sci; 2024 Jan; 9(1):18-29. PubMed ID: 38362338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
